enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lorcaserin - Wikipedia

   en.wikipedia.org/wiki/Lorcaserin

   Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus , a region of the brain which is known to control appetite. [ 6 ]

3. 25 Belt-Busting Obesity Facts - AOL

   www.aol.com/news/2013-05-18-25-belt-busting...

   The Food and Drug Administration approved the weight-loss therapy Belviq from Arena Pharmaceuticals in June 2012. It took nearly one year for the company to gain marketing approval, but Belviq's ...

4. Cheaper Obesity Drugs Available (for Half of Some Americans)

   www.aol.com/news/2014-02-24-cheaper-obesity...

   For premium support please call: 800-290-4726 more ways to reach us

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   SGLT2 inhibitors cause the loss of 60–100 grams (2.1–3.5 oz) glucose in the urine each day and are associated with a modest, sustained weight loss of 1.5–2 kilograms (3.3–4.4 lb) in people with type 2 diabetes. The weight loss is less than expected due to compensatory increases in energy intake, but is additive when combined with GLP-1 ...

6. Arena Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Arena_Pharmaceuticals

   Lorcaserin is approved for use in adults with a body mass index (BMI) of 30 or greater, which is considered obese, or adults with a BMI of 27 or greater and who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. However, sales of Belviq were disappointing.

7. New Obesity Drug Hits the Market - AOL

   www.aol.com/news/2013-06-07-new-obesity-drug...

   For premium support please call: 800-290-4726 more ways to reach us